Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 11;13(16):11096-11120.
doi: 10.1039/d3ra01383a. eCollection 2023 Apr 3.

Anticancer therapeutic potential of benzofuran scaffolds

Affiliations
Review

Anticancer therapeutic potential of benzofuran scaffolds

Ashraf A Abbas et al. RSC Adv. .

Abstract

Benzofuran moiety is the main component of many biologically active natural and synthetic heterocycles. These heterocycles have unique therapeutic potentials and are involved in various clinical drugs. The reported results confirmed the extraordinary inhibitory potency of such benzofurans against a panel of human cancer cell lines compared with a wide array of reference anticancer drugs. Several publications about the anticancer potencies of benzofuran-based heterocycles were encountered. The recent developments of anticancer activities of both natural and synthetic benzofuran scaffolds during 2019-2022 are thoroughly covered. Many of the described benzofurans are promising candidates for development as anticancer agents based on their outstanding inhibitory potency against a panel of human cancer cells compared with reference anticancer drugs. These findings encourage medicinal chemists to explore new areas to improve human health and reduce suffering.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Structures of some natural benzofuran derivatives with anticancer activities.
Fig. 2
Fig. 2. Some clinical drugs containing benzofuran scaffolds.
Fig. 3
Fig. 3. Summarized molecular targets for benzofurans as anticancer compounds.
None
Ashraf A. Abbas
None
Kamal M. Dawood

References

    1. Gao B. Yang B. Feng X. Li C. Nat. Prod. Rep. 2022;39:139–162. - PubMed
    1. Cossy L. Guerinot A. Adv. Heterocycl. Chem. 2016;119:107–142.
    1. Chand K. Hiremathad A. Singh M. Santos M. A. Keri R. S. Pharmacol. Rep. 2017;69:281–295. - PubMed
    1. Miao Y. H. Hu Y. H. Yang J. Liu T. Sun J. Wang X. J. RSC Adv. 2019;9:27510–27540. - PMC - PubMed
    1. Radadiya A. Shah A. Eur. J. Med. Chem. 2015;97:356–376. - PubMed